期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
脊髓硬脊膜动静脉瘘1例并文献复习
1
作者 散丹 甄瑾 《临床荟萃》 CAS 2024年第9期825-827,共3页
目的探讨脊髓硬脊膜动静脉瘘(spinal dural arteriovenous fistulas,SDAVF)的临床表现、发病机制和影像学特点。方法回顾1例SDAVF患者的诊治过程,并复习相关文献。结果患者为61岁男性,以行走困难为首发症状,随后出现感觉及尿便障碍,脊... 目的探讨脊髓硬脊膜动静脉瘘(spinal dural arteriovenous fistulas,SDAVF)的临床表现、发病机制和影像学特点。方法回顾1例SDAVF患者的诊治过程,并复习相关文献。结果患者为61岁男性,以行走困难为首发症状,随后出现感觉及尿便障碍,脊柱磁共振成像可见条状T2长信号,脊髓血管造影显示L1节段可见脊髓动静脉瘘。结论SDAVF较为罕见,且临床表现不典型,脊髓血管造影是确诊的金标准,确诊后应尽快行手术治疗。 展开更多
关键词 动静脉瘘 诊断 磁共振成像 血管造影术
下载PDF
急性大动脉粥样硬化型脑梗死患者血清CTRP5水平的相关性分析
2
作者 散丹 李自如 袁军 《国际医药卫生导报》 2024年第9期1459-1464,共6页
目的探究血清补体C1q关联的肿瘤坏死因子相关蛋白5(CTRP5)水平在急性大动脉粥样硬化(ALAA)型脑梗死患者病程中的血清表达水平及其潜在关联性特征。方法前瞻性研究,选取2022年12月至2023年8月在内蒙古自治区人民医院住院的112例首次发病A... 目的探究血清补体C1q关联的肿瘤坏死因子相关蛋白5(CTRP5)水平在急性大动脉粥样硬化(ALAA)型脑梗死患者病程中的血清表达水平及其潜在关联性特征。方法前瞻性研究,选取2022年12月至2023年8月在内蒙古自治区人民医院住院的112例首次发病ALAA型脑梗死患者[ALAA型脑梗死组,男69例,女43例,年龄(64.25±9.42)岁],并配以55例虽有颅内外大动脉粥样硬化却未表现出脑梗死症状患者[大动脉粥样硬化(LAA)型非脑梗死组,男36例,女19例,年龄(66.98±9.78)岁]、41例存在颅内外大动脉斑块患者[斑块组,男18例,女23例,年龄(65.10±7.63)岁]及37名健康体检者[正常组,男18例,女19例,年龄(63.03±10.85)岁]。通过酶联免疫吸附法(ELISA),测定所有入组人员的血清CTRP5水平,比较ALAA型脑梗死组、非脑梗死对照组(包括斑块组和正常组)之间血清CTRP5水平。统计学方法采用t检验、非参数U检验、χ^(2)检验。结果正常组与其他3组(即ALAA型脑梗死组、LAA型非脑梗死组以及斑块组)、斑块组与脑梗死组、斑块组与非脑梗死组之间血清CTRP5水平比较,差异均有统计学意义(F=5259.50、538.00、5327.00、51466.50、5441.00,均P<0.05)。经logistic回归分析,CTRP5水平与患病风险间存在正相关联系(OR值为0.002,95%CI 0~0.171)。CTRP5的受试者操作特征曲线(ROC)分析中得出,ROC曲线下面积为0.937,95%CI 0.895~0.980,证明了CTRP5在鉴别ALAA型脑梗死病例方面具备一定的有效性和准确性。结论血清CTRP5水平与ALAA型脑梗死及大动脉粥样硬化有一定相关性;并未检测到血清CTRP5水平与神经功能缺损的严重程度之间存在明显的关联关系;血清中CTRP5水平有望成为预测ALAA型脑梗死以及评估大动脉粥样硬化风险的一种潜在生物标志物。 展开更多
关键词 急性大动脉粥样硬化 补体C1q关联的肿瘤坏死因子相关蛋白5 酶联免疫吸附法 相关性分析
下载PDF
C-terminal domain of Chk1 regulates its subcellular location and kinase activity for DNA repair 被引量:1
3
作者 NING LiFeng WANG HuiPing +1 位作者 san dan sanG JianLi 《Chinese Science Bulletin》 SCIE EI CAS 2011年第30期3138-3147,共10页
Effector kinase Chk1 is an evolutionarily conserved protein kinase. It is a key mediator linking the mechanisms that monitor DNA integrity to components of the cell cycle engine. In this study, recombinant vectors pEG... Effector kinase Chk1 is an evolutionarily conserved protein kinase. It is a key mediator linking the mechanisms that monitor DNA integrity to components of the cell cycle engine. In this study, recombinant vectors pEGFP-C1-Chk1/C 288/C 334/C 368 were constructed and transfected into HeLa cells to study the effect of the Chk1 regulatory domain on the regulation of subcellular Chk1 location in response to DNA damage. We found that DNA damage-induced nuclear accumulation is regulated by 34 amino acids (334–368) in the C-terminal regulatory domain. Recombinant vectors pXJ41-Chk1/C 288/C 334/C 368 were co-transfected with reporter plasmid pEGFP-N2 into HeLa cells to study the repair abilities of the different human Chk1 truncation mutants. In addition, recombinant vectors were transfected into HeLa cells to study the effects of the different truncation mutants on the cell cycle. Furthermore, to study the kinase activity of the different truncation mutants, Ser216 phosphorylation of Cdc25C was studied by Western blot analysis. We found that the enzymatic activity of C 368, missing the 108 C-terminal amino acids (368–476), was higher than that of full-length Chk1, and C 368 delayed the cell cycle progression. The enzymatic activity of C 334, missing the 142 C-terminal amino acids (334–476), was equivalent to that of full-length Chk1. C 288, missing the 188 C-terminal amino acids (288–476), had almost no enzymatic activity, suggesting that the regulatory domain contains both inhibitory and regulatory elements. This study provides useful information for further research on Chk1 function. 展开更多
关键词 亚细胞定位 激酶活性 DNA修复 HELA细胞 DNA损伤 细胞周期 重组载体 BLOT分析
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部